On April 21, 2009, Jarden Corporation, a Delaware corporation (the "Company"), entered into an Underwriting Agreement (the "Underwriting Agreement") with Barclays Capital Inc. (the "Underwriter"). Subject to the terms and conditions of the Underwriting Agreement, the Company agreed to sell to the Underwriter 12,000,000 shares of the Company's common stock, par value $0.01 per share (the "Common Stock"). The shares of Common Stock were offered to the public at a price of $17.50 per share. The shares of Common Stock were offered to the Underwriters at a price of $17.03 per share. The closing with respect to the sale of the shares of Common Stock is anticipated to occur on April 27, 2009.

The shares of Common Stock are being issued and sold pursuant to the Company's automatic shelf registration statement on Form S-3 (No. 333-138302) filed with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the "Registration Statement"). The Underwriting Agreement contains customary representations, warranties, conditions to closing, indemnification and obligations of the parties. The Company has also agreed to indemnify the Underwriter against certain liabilities, including civil liabilities under the Securities Act of 1933, as amended, or to contribute to payments that the Underwriter may be required to make in respect of those liabilities.

The foregoing summary of the Underwriting Agreement is qualified in its entirety by reference to the text of the Underwriting Agreement, which is attached as Exhibit 1.1 hereto and is incorporated herein by reference to this Current Report on Form 8-K and into the Registration Statement.

(d) Exhibits. The following exhibit is hereby filed as part of this Current Report on Form 8-K:

Exhibit No.    Description
1.1            Underwriting Agreement, dated April 21, 2009, between Jarden Corporation
               and Barclays Capital Inc.